Skip Navigation



Human Molecular Genetics Advance Access published online on June 9, 2004

Human Molecular Genetics, doi:10.1093/hmg/ddh178
© 2004 by Oxford University Press
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Material
Right arrow All Versions of this Article:
13/15/1551    most recent
ddh178v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Elomaa, O.
Right arrow Articles by Saarialho-Kere, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elomaa, O.
Right arrow Articles by Saarialho-Kere, U.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Article

Transgenic mouse models support HCR as an effector gene in the PSORS1 locus

Outi Elomaa 1, Inkeri Majuri 1, Sari Suomela 2, Kati Asumalahti 3, Hong Jiao 4, Zahra Mirzaei 4, Bjorn Rozell 5, Karin Dahlman-Wright 4, Johanna Pispa 6, Juha Kere 7*, Ulpu Saarialho-Kere 8

1 Departments of Medical Genetics, University of Helsinki, and Helsinki University Central Hospital, Helsinki, Finland
2 Departments of Dermatology, University of Helsinki, and Helsinki University Central Hospital, Helsinki, Finland
3 Departments of Medical Genetics, University of Helsinki, and Helsinki University Central Hospital, Helsinki, Finland; Departments of Dermatology, University of Helsinki, and Helsinki University Central Hospital, Helsinki, Finland
4 Department of Biosciences at Novum, Huddinge University Hospital, Huddinge, Sweden
5 Division of Clinical Research Center and Pathology, Department of Laboratory Medicine, Huddinge University Hospital, Huddinge, Sweden
6 Institute of Biotechnology, University of Helsinki, and Helsinki University Central Hospital, Helsinki, Finland
7 Departments of Medical Genetics, University of Helsinki, and Helsinki University Central Hospital, Helsinki, Finland; Department of Biosciences at Novum, Karolinska Institutet, Huddinge University Hospital, 14157 Huddinge, Sweden; Division of Clinical Research Center and Pathology, Department of Laboratory Medicine, Huddinge University Hospital, Huddinge, Sweden
8 Departments of Dermatology, University of Helsinki, and Helsinki University Central Hospital, Helsinki, Finland; Karolinska Institutet at Stockholm Soder Hospital, Stockholm, Sweden

* To whom correspondence should be addressed. E-mail: juha.kere{at}biosci.ki.se.


   Abstract

Genetic susceptibility for psoriasis is regulated to the greatest extent by the PSORS1 locus. Three psoriasis associated susceptibility alleles have been identified within it, namely HLACw6, HCR*WWCC and CDSN*5, but strong linkage disequilibrium between them has made it difficult to distinguish their individual genetic effects, and animal models to study their effects are not known. In order to study the function of HCR, we engineered transgenic mice with either a nonrisk allele of HCR or the HCR*WWCC risk allele under the control of the cytokeratin-14 promoter. These choices were motivated by the apparently dominant effect of PSORS1 on psoriasis susceptibility and the physiological expression of HCR in basal keratinocytes. Transgenic mice appeared phenotypically normal, and histologically their skin was indistinguishable from wild-type mice. Expression studies using Affymetrix arrays suggested that the HCR risk allele has specific functional consequences relevant to the pathogenesis of psoriasis. Comparison of gene expression changes between nonrisk and risk allele mice revealed similarities to previous observations in human psoriatic skin, including upregulation of cytokeratins 6, 16 and 17 in risk allele mice. We also observed changes in the expression of genes associated with terminal differentiation and formation of the cornified cell envelope. Our results support the concept that HCR may constitute an essential gene in the PSORS1 locus. These observations are also compatible with a model that a susceptibility gene for psoriasis induces changes that are contributory but not sufficient alone to produce the clinical phenotype.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
I. Tiala, J. Wakkinen, S. Suomela, P. Puolakkainen, R. Tammi, S. Forsberg, O. Rollman, K. Kainu, B. Rozell, J. Kere, et al.
The PSORS1 locus gene CCHCR1 affects keratinocyte proliferation in transgenic mice
Hum. Mol. Genet., April 1, 2008; 17(7): 1043 - 1051.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
W. L. Miller
StAR Search--What We Know about How the Steroidogenic Acute Regulatory Protein Mediates Mitochondrial Cholesterol Import
Mol. Endocrinol., March 1, 2007; 21(3): 589 - 601.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
N. Corbi, T. Bruno, R. De Angelis, M. Di Padova, V. Libri, M. G. Di Certo, L. Spinardi, A. Floridi, M. Fanciulli, and C. Passananti
RNA Polymerase II subunit 3 is retained in the cytoplasm by its interaction with HCR, the psoriasis vulgaris candidate gene product
J. Cell Sci., September 15, 2005; 118(18): 4253 - 4260.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc BHome page
J. Kere
Mapping and identifying genes for asthma and psoriasis
Phil Trans R Soc B, August 29, 2005; 360(1460): 1551 - 1561.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.